Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Yehia I. Mohamed, Sunyoung S. Lee, Tarik Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao, Khaled Elsayes, Jeffrey S. Morris, Robert A. Wolff, Rikita Hiatia, Aliya Qayyum, Asif Rashid, Dan G. Duda, James C. Yao, Michael Lapelusa, Eugene J. Koay, Armeen Mahvash, Ahmed Al Azzam, Ecaterina E. Dumbrava, Manal HassanHesham M. Amin, Ahmed Omar Kaseb

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science